Activities

428

Interasma and EAACI Asthma Section are holding a Joint Meeting, in Bilbao, Spain on 27 - 30 November, 2004. Outstanding personalities from the clinical and research area of allergy and clinical immunology will gather together to discuss on Asthma and Rhinitis, starting from the main guidelines to patient's care. The INTERASMA-EAACI Asthma Section Joint Meeting is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.  Following EACCME’s accreditation, the meeting has now been awarded 21 European CME credits (ECMEC).

Visit the official website of the Organisers, www.interasma.org/Bilbao2004 to get more information on the: 

- Preliminary Program
- On line registration
- Abstract submission  
- Student Grant applications
- EAACI CME Accredited event     
- Specific Adult and Paediatric tracks

The deadline for the grant application and abstract submission has now been extended to October 4th, 2004.

Last updated 14 July 2009
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel